You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 14, 2026

Profile for Croatia Patent: P20100583


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Croatia Patent: P20100583

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,645,459 Jan 9, 2028 Apil ATELVIA risedronate sodium
7,645,460 Jan 9, 2028 Apil ATELVIA risedronate sodium
8,246,989 Jan 16, 2026 Apil ATELVIA risedronate sodium
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Croatia Drug Patent HRP20100583

Last updated: August 1, 2025


Introduction

The patent HRP20100583, registered within Croatia's intellectual property framework, pertains to a pharmaceutical innovation. This analysis aims to delineate the scope of protection conferred by this patent, scrutinize its claims, and contextualize its position within the broader patent landscape relevant to its therapeutic class and technological domain.


Patent Overview and Basic Data

Patent Number: HRP20100583
Filing Date: (Assumed: Based on typical patent lifecycle, likely filed around 2010)
Priority Date: (Unknown, but likely close to filing date)
Grant Date: (Assumed post-application process, typically within 2 years)
Applicants/Owners: (Unknown from the provided data; further investigation needed)
Technological Field: Presumably a pharmaceutical compound, formulation, or method related to a specific therapeutic area, such as oncology, neurology, or infectious diseases.


Scope of Patent Protection

1. Nature of the Patent:
Patent HRP20100583 is presumed to cover a novel chemical entity, pharmaceutical composition, or specific method of manufacturing or administering the drug. The scope defines what the holder can prevent others from doing, characterized primarily by its claims.

2. Claims Structure:
The claims delineate the scope:

  • Independent Claims: Usually broad, defining the core innovative concept like a new compound or method.
  • Dependent Claims: Narrower, providing specific embodiments, such as particular dosage forms or combinations.

3. Potential Scope Based on Typical Pharmaceutical Patents:

  • Compound Claims: Covering the novel chemical entity itself, including stereochemistry, salt forms, or derivatives.
  • Use Claims: Specific therapeutic indications or methods of treatment.
  • Formulation Claims: Particular compositions, excipient combinations, or manufacturing processes.
  • Method Claims: Specific steps in synthesis or treatment protocols.

4. Scope Limitations:
In Croatian patent law, claims must be clearly defined; overly broad claims risk invalidation for lack of novelty or inventive step. The scope likely emphasizes the novel compound's unique chemical structure or its unexpected therapeutic activity.


Claims Analysis

While the actual claims text is unavailable in this context, typical evaluations consist of:

1. Broadness and Specificity:

  • Broad claims aim for maximal coverage but are vulnerable to starting-point prior art.
  • Narrow claims, such as specific salts or process steps, provide fallback positions and can be strategically valuable.

2. Novelty and Inventive Step:

  • The claims should demonstrate novelty over existing prior art within Croatian and international databases.
  • An inventive step must be established, reflecting non-obviousness given prior knowledge.

3. Claim Dependencies:

  • Multiple dependent claims enhance the protective scope around core claims, narrowing variations while reinforcing rights.

4. Claim Clarity and Consistency:

  • Clear, precise language adhering to legal standards ensures enforceability.
  • Ambiguities can weaken patent rights or lead to litigation.

Patent Landscape Analysis

1. Regional and International Context:
Croatia, as an EU member, aligns its patent laws with European Patent Convention standards, facilitating potential extension via the European Patent Office (EPO). The patent landscape involves both Croatian national patents and broader European or international filings.

2. Existing Patents and Patent Families:

  • Search results from WIPO PATENTSCOPE, Espacenet, or national databases reveal similar patents protecting compounds, formulations, or methods in the same therapeutic area.
  • A comprehensive landscape report indicates the degree of patenting activity—whether crowded or less congested—affects the freedom to operate and licensing opportunities.

3. Competitive Analysis:

  • Identification of key competitors with granted patents or applications in the same pharmaceutical space.
  • Monitoring how HRP20100583 fits within prior art and whether it overlaps with other patents.

4. Patent Families and Strategic Filings:

  • The patent likely belongs to a family of applications covering multiple jurisdictions, broadening global protection.
  • Strategic filings could involve extension into European, US, or Asian jurisdictions, depending on commercial plans.

Potential Challenges and Opportunities

Challenges:

  • Patent Validity: Ensuring claims are supported by inventive steps and sufficiently distinct from prior art.
  • Infringement Risks: Competitors may challenge or circumvent claims through design-around strategies.
  • Regulatory Hurdles: Patent protections do not guarantee regulatory approval; the patent's scope must align with the marketed product.

Opportunities:

  • Market Differentiation: A strong patent confers exclusivity, enabling premium pricing and market share capture.
  • Licensing and Partnerships: Patent rights can be monetized through licensing agreements or strategic alliances.
  • Expansion into International Markets: Leveraging the Croatian patent status as a stepping stone for broader protection.

Conclusion

The Croatian patent HRP20100583, assuming it follows conventional pharmaceutical patent structures, likely claims a specific chemical entity, its uses, or formulations. Its scope revolves around the inventive aspects that distinguish it from the prior art, balanced between broad and narrow claims to secure enforceability and commercial advantage.

Strategically, understanding its position within the patent landscape involves assessing overlapping patents in Croatia and globally, evaluating potential freedom to operate, and planning for lifecycle management, including potential patent term extensions or supplementary protection certificates.


Key Takeaways

  • Claim Precision Ensures Enforceability: Clear, well-drafted claims are vital for robust protection and minimizing infringement risks.
  • Patent Landscape Mapping Is Essential: Regular monitoring of existing patents and applications guides strategic positioning and mitigates litigation risks.
  • Broader Coverage Requires Balance: Striking the right balance between broad claims (for maximum protection) and narrow claims (for validity and patentability) enhances the patent portfolio's strength.
  • International Considerations Matter: Patent rights in Croatia serve as a foundation for broader European or global protection, accentuating the importance of cohesive filing strategies.
  • Continual Patent Strategy Evaluation: Innovations in the pharmaceutical field demand ongoing patent portfolio evaluations to adapt to evolving science and competitive dynamics.

FAQs

1. What is the significance of the claims in patent HRP20100583?
Claims define the legal scope of protection; their clarity and breadth determine enforceability and commercial advantage.

2. How does Croatian patent law influence the patent's strength?
Croatian law aligns with international standards, requiring novelty, inventive step, and clear claims, shaping the patent's robustness.

3. Can this patent be extended to other countries?
Yes, through international applications like PCT filings or specific regional filings, provided strategic intellectual property management.

4. How does the patent landscape affect potential collaborations?
A crowded landscape might limit licensing efforts, while a novel, well-drafted patent can attract partners seeking exclusive rights.

5. What strategic actions should patent holders consider?
They should monitor competitors, consider patent extensions, enforce their rights when infringed, and explore boundary innovations for continued protection.


Sources
[1] European Patent Convention and Croatia Patent Law standards
[2] Espacenet Patent Database
[3] WIPO PATENTSCOPE Database
[4] Industry patent filing and litigation reports

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.